TechnoMedica Corporation completed the disposal of 19,800 shares of treasury stock at 1,968 yen per share on July 24, 2026, raising a total of 38,966,400 yen. The disposal was allocated to four directors.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6678","jir_company_name":"TechnoMedica Corporation","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-07-24","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/6678-20260724-01.pdf","jir_short_summary":"TechnoMedica Corporation completed the disposal of 19,800 shares of treasury stock at 1,968 yen per share on July 24, 2026, raising a total of 38,966,400 yen. The disposal was allocated to four directors.","jir_summary":"### Overview of Capital Policy\nTechnoMedica Corporation completed today the disposal of treasury stock approved at the Board of Directors meeting held on July 1, 2026. The shares subject to disposal were 19,800 common shares, allocated at 1,968 yen per share, raising a total of 38,966,400 yen. The recipients were four directors (excluding directors who are Audit & Supervisory Committee members). This disposal was carried out as part of the stock compensation system, aiming to enhance shareholder value and strengthen employee incentives.\n\n### Impact on Shareholders and Future Outlook\nThe impact of this treasury stock disposal on the total issued shares is considered limited in terms of dilution. The funds raised are expected to be used for shareholder returns and business investments, contributing to strengthening the company\u2019s financial position. Moving forward, the company plans to continue implementing measures aimed at increasing shareholder value as part of its capital policy. Investors will view this as a stable capital policy and a component of shareholder return strategies.","jir_financial_highlights":"Number of shares of treasury stock disposed: 19,800 shares (Unknown)\nDisposal amount: 38,966,400 yen (Unknown)\nDisposal price per share: 1,968 yen (Unknown)","jir_category":"","jir_hashtags":"#TechnoMedicaCorporation, #ShareBuyback, #JapanStocks","jir_key_figures":"Number of shares of treasury stock disposed: 19,800 shares\nDisposal amount: 38,966,400 yen\nDisposal price per share: 1,968 yen","jir_meta_title":"\u3010TechnoMedica Corporation\u3011Share Buyback Completed\uff5cJuly 2026","jir_meta_description":"TechnoMedica Corporation disposed of 19,800 shares of treasury stock on July 24, 2026, raising a total of 38,966,400 yen. Aims to enhance shareholder value as part of its capital policy.","jir_og_title":"\u3010TechnoMedica\u3011Share Buyback Completed\uff5cJuly 2026","jir_og_description":"TechnoMedica is disposing of treasury stock and promoting capital policy. An important initiative for shareholder returns and financial strengthening.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57947,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-87830","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n